Krumholz Receives the American Heart Association's Clinical Research Prize
Krumholz was recognized “for his work as a founding leader in the field of outcomes research. His work has led to improvements in the quality of care and outcomes for millions of patients nationwide and beyond,” said American Heart Association President Robert A. Harrington, MD, FAHA.
Yale Offers New Medication for Fatal Disease
Yale Medicine physicians were the first in Connecticut to offer a new medication for hereditary transthyretin-mediated amyloidosis (hATTR), a life-threatening genetic mutation that causes transport proteins called transthyretin to cluster together and deposit amyloids in the peripheral nerves, heart, kidney, and gastrointestinal tract.
NIH Grants Fund Image-Guided Therapy After a Heart Attack
A team of researchers from the Yale School of Medicine and the University of Washington will use ultrasound to guide the delivery of theranostic hydrogels into the heart to prevent dilation of the heart post-MI and subsequent heart failure.
New Consensus for Managing Patients Hospitalized with Heart Failure
The American Heart Association estimates that by 2030 more than 8 million Americans will be diagnosed with chronic heart failure (HF). This condition may lead to kidney failure, liver damage, and other complications. The 2019 American College of Cardiology report provides clinical tools to improve the management of HF patients.